New Treatment For Leaky Lungs -- Research Summary
BACKGROUND: Millions of people around the world are living with lung diseases like emphysema. According to the American Lung Association, more than 3.1 million people in the United States have been diagnosed with it. As a result of the disease, the tiny air sacs that make up the lungs are either enlarged or destroyed, and the exchange of oxygen and carbon dioxide with the blood is impaired. This leads to difficulty breathing, coughing and shortness of breath. The most common cause of emphysema is smoking. (SOURCE: American Lung Association)
TREATMENT OPTIONS: Many people with emphysema do not respond well to medical treatments and are not eligible for major surgeries. Available treatments for emphysema are generally palliative (they alleviate pain without curing) and include medications, home oxygen therapy, pulmonary rehabilitation, lung volume reduction surgery and lung transplantation. The IBV Valve System is under investigation in the U.S. as a new treatment option for patients who have severe emphysema. It is also an investigational device in Canada. (SOURCE: National Center for Biotechnology Information)
HOW IT WORKS: The IBV Spiration Valve is a minimally invasive treatment that is designed to redirect airflow from diseased portions of the lung to healthier areas.
The main goal of the device is to block the entrance of air into diseased regions of the lungs and also prevent air from escaping from air leaks. Air leaks are a common complication of surgery.
The leaks are caused by lung tissue that has not completely closed and sealed, resulting in an accumulation of air in the chest that can cause difficulty breathing. They can occur after lung surgery or as a consequence of certain serious lung diseases.
During the procedure, a catheter is passed through a flexible tube that is passed into the bronchial tubes through the nose or mouth. It deploys small umbrella-shaped valves into the airways of the most diseased upper parts of the lungs. The valves are designed to be permanent but can be removed if necessary. In Europe, the system has already received market clearance for the treatment of emphysema and to resolve air leaks. (SOURCE: www.spiration.com) MORE
FOR MORE INFORMATION, PLEASE CONTACT:
Ellen Fiss, Public Relations Manager
Tampa General Hospital
Tampa, FL
efiss@tgh.org
http://www.tgh.org
New Treatment For Leaky Lungs -- Research Summary | Medical News and Health Information
New Treatment For Leaky Lungs | Medical News and Health Information
New Treatment For Leaky Lungs -- In Depth Doctor's Interview | Medical News and Health Information
.png)
No hay comentarios:
Publicar un comentario